An Eye Exam Found Conjunctival Melanoma Before Symptoms Appeared

A small patch of discoloration on the white of one woman’s eye turned out to be conjunctival melanoma, a rare eye cancer. She had no pain or vision changes when an ophthalmologist spotted it during a routine exam in March 2025. Her experience shows how an eye check can uncover a problem before it causes noticeable symptoms, while also illustrating why a suspicious mark needs expert assessment rather than guesswork.

At 50, the writer felt settled for the first time. She had bought a home in a small New England town, built a life with her partner, and adopted a Mini Rex rabbit. The mark her eye doctor noticed was near the iris. It looked like a tiny, blurred freckle on the white part of her eye.

The doctor said it was probably benign but recommended testing for melanoma. The writer was not initially worried. Her eyes felt normal, and she had no pain or flashes of light, symptoms sometimes associated with eye conditions. She had also had several skin moles biopsied in the past; each had been harmless. She assumed this result would be similar.

The biopsy was brief. A surgeon numbed the eye and removed a small sample. It felt scratchy for a day or two. About a week later, the surgeon called: the sample contained severely atypical cells, with areas that could be considered melanoma. The diagnosis was conjunctival melanoma, a cancer affecting the conjunctiva, the clear tissue covering the white of the eye and lining the eyelids.

Getting a specialist’s view

The surgeon said the cancer appeared to have been found early and recommended removing the tumor soon. The writer recalls being told she might also need chemotherapy, with a risk to her vision. In the shock of the call, she did not ask about her prognosis or the possibility of spread. At first, she felt more irritated by the prospect of extra medical appointments than frightened.

A conversation with an acquaintance who had experienced another type of eye cancer made the situation feel more serious. The writer called her surgeon again, then decided to seek care at a clinic specializing in eye tumors. Her partner and friends encouraged her to consult a specialist; a neighbor who had retired from Massachusetts General Hospital pointed her toward Mass Eye and Ear in Boston. She took the clinic’s first available appointment.

She also chose to avoid searching the diagnosis online, asking her partner to share anything he learned that seemed essential. That was a personal way to manage the uncertainty. For people facing an unfamiliar diagnosis, a specialist can help explain which information applies to their specific case and what questions to address next.

Two weeks later, a cornea specialist overseeing her care prescribed chemotherapy eye drops. The drops were intended to limit cancer growth while she waited for surgery and to treat possible microscopic spread that could not be seen. The doctor warned that treatment carried a meaningful risk of worsening vision. After getting a second opinion from the first surgeon, the writer decided to use the drops. She completed two rounds without immediate side effects, though she remained concerned about possible effects on her sight.

Surgery and recovery

About two months after diagnosis, she had surgery at Mass Eye and Ear under conscious sedation. She was awake but calm, and her eye was numbed. The surgeon removed the visible tumor. The writer explains that eye surgery may require a different approach from removing a skin melanoma: because the eye’s surface is delicate, the aim is to take out the affected tissue while preserving as much healthy tissue as possible.

The team also removed a second discolored area for testing and sampled a normal-looking part of the eye’s white to check for cancer cells that might not be visible. They used cryotherapy, which freezes tissue, around the sampled areas to destroy any cancer cells that could remain, then placed corneal grafts to support healing and reduce scarring. She left the hospital around lunchtime with a protective shield over the eye and no pain, in part because the anesthetic had not yet worn off.

The next week was difficult. Her vision in the treated eye was poor, her eye watered and felt sore and scratchy, and ointment further blurred her sight. Even looking from one friend to another during a visit hurt. She also felt exhausted and low, worrying about whether the cancer had spread or whether scarring might permanently affect her vision. Those feared outcomes did not occur, but she had to wait for the biopsy results before knowing how much of the tumor had been removed.

At a follow-up visit, her doctor said the entire melanoma had been excised and there was no evidence of spread. Some precancerous cells remained, however, with a 30% chance of becoming melanoma within five years. After the eye healed, the writer completed a third round of chemotherapy drops. Her vision did not worsen compared with its prior state, and she was left with a small scar near the tear duct. A biopsy of a few spots in her other eye found no cancer.

What the case can and cannot tell us

The writer’s experience is one person’s account, not a measure of how often eye marks are cancerous or how treatment will affect others. Conjunctival melanoma is rare, and the course of care depends on the individual findings. Her doctor will continue to monitor her with regular eye examinations, using a dye to make abnormal areas easier to see.

Ivana Kim, M.D., director of the Ocular Melanoma Center at Mass Eye and Ear and an associate professor of ophthalmology at Harvard Medical School, says fair skin and light-colored eyes are associated with higher risk of eye cancer. Finding a cancer early can improve the chance of preserving the eye and vision, though outcomes vary by cancer type and individual circumstances.

Conjunctival melanoma is one of several cancers that can affect the eye. Uveal melanoma, which develops in the middle layer of the eye, is among the more common eye cancers in adults; one treatment is plaque radiation, in which a disc containing radioactive seeds is temporarily attached to the eye. Intraocular lymphoma is another type and is rare, with diagnoses most often occurring in adults over 50. These conditions are distinct, and their treatments are not interchangeable.

The source article cites research estimating that about 25% of conjunctival melanoma cases lead to death. That figure underscores why the diagnosis deserves careful medical follow-up, but it cannot predict an individual’s outcome. In the writer’s case, doctors found no spread after surgery and continue to monitor the remaining precancerous cells.

Why routine eye care matters

Eye examinations can identify more than changes in sight. Examination of the nerves and blood vessels may also reveal signs associated with conditions such as diabetes, thyroid disease, high blood pressure, and Sjögren’s disease. Regular checks can also help detect eye problems that may have few early symptoms.

Two examples are age-related macular degeneration and glaucoma. Macular degeneration affects the central part of the retina and can impair central vision. It affects nearly 20 million people in the United States, most of them over 60, according to the source article. Smoking and a high-fat diet are among the risk factors a person may be able to change; Dr. Kim recommends a Mediterranean-style diet.

Glaucoma can damage the optic nerve, sometimes as pressure builds inside the eye. It may create blind spots and can lead to severe vision loss if it is not identified and treated. The American Academy of Ophthalmology recommends a baseline eye exam at least once in a person’s 20s and twice in their 30s, followed by exams as often as an eye doctor advises based on health and risk factors.

A new or changing spot on the eye is not automatically cancer. But a clinician can assess whether it needs monitoring or further testing, and people who notice a change can raise it with an eye doctor. The writer’s main takeaway is equally practical: routine eye exams can matter even when glasses are not needed and vision feels fine. She credits early detection, specialist care, and support from her partner, friends, neighbors, and pet BunBun with helping her through treatment.